Showing results (41-50 of 128) with videos related to
Sort By:
Pageof 13
Immunologic Research|May 25, 2006
Redirection of T cells by delivering a transgenic mouse-derived MDM2 tumor antigen-specific TCR and its humanized derivative is governed by the CD8 coreceptor and affects natural human TCR expressionRalf-Holger Voss, Jürgen Kuball, Renate Engel, et al.Journal of Immunological Methods|October 30, 2008
Combining MHC tetramer and intracellular cytokine staining for CD8(+) T cells to reveal antigenic epitopes naturally presented on tumor cellsNektaria Dimopoulos, Heather M Jackson, Lisa Ebert, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 26, 2008
An essential role for the stalk region of CD8 beta in the coreceptor function of CD8Lorna Rettig, Louise McNeill, Nitza Sarner, et al.International Journal of Cancer|December 10, 2009
Novel soluble HLA-A2/MELAN-A complexes selectively stain a differentiation defective subpopulation of CD8+ T cells in patients with melanomaPhilippe Guillaume, Petra Baumgaertner, Laurence Neff, et al.Nature Immunology|February 20, 2004
Cis association of Ly49A with MHC class I restricts natural killer cell inhibitionMarie-Agnès Doucey, Léonardo Scarpellino, Jacques Zimmer, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2006
Soluble MHC-peptide complexes containing long rigid linkers abolish CTL-mediated cytotoxicityGeorgi S Angelov, Philippe Guillaume, Marek Cebecauer, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 25, 2009
Vaccination with a recombinant protein encoding the tumor-specific antigen NY-ESO-1 elicits an A2/157-165-specific CTL repertoire structurally distinct and of reduced tumor reactivity than that elicited by spontaneous immune responses to NY-ESO-1-expressing TumorsGilles Bioley, Philippe Guillaume, Immanuel Luescher, et al.The Journal of Biological Chemistry|October 31, 2002
Soluble major histocompatibility complex-peptide octamers with impaired CD8 binding selectively induce Fas-dependent apoptosisPhilippe Guillaume, Daniel F Legler, Nicole Boucheron, et al.Immunology Letters|June 16, 2009
Fab antibodies capable of blocking T cells by competitive binding have the identical specificity but a higher affinity to the MHC-peptide-complex than the T cell receptorFrank Neumann, Christine Sturm, Martin Hülsmeyer, et al.Cancer Immunology, Immunotherapy : CII|November 15, 2011
Enhanced cytotoxicity and decreased CD8 dependence of human cancer-specific cytotoxic T lymphocytes after vaccination with low peptide doseTanja Lövgren, Petra Baumgaertner, Sébastien Wieckowski, et al.Pageof 13